drugset / Trial / NCT00004767
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
Phase 2
Completed
20 enrolled
National Center for Research Resources (NCRR)
Johns Hopkins University · collab
Treatment
Summary
OBJECTIVES: I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium phenylacetate, and dietary intervention in patients with urea cycle disorders.
Timeline
- Start
- 1985-01
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Benzoate | Small molecule | — | Intravenous |
| Subject | Sodium Phenylacetate | Small molecule | — | Intravenous |
| Subject | Sodium Phenylbutyrate | Small molecule | — | Oral |